No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - General
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. operates as a biopharmaceutical enterprise, primarily engaged in the discovery, development, production, and sale of medicinal products. The company's core focus is on pharmaceuticals designed for the diagnosis and management of allergic conditions, which it supplies to both the Chinese domestic market and international clientele. Additionally, its portfolio encompasses various skincare lines and stem cell-related solutions. The firm's main offices are located in Huzhou, China.
www.wolwobiotech.comNo one on the platform currently holds 300357.SZ.
No tracked institution reports a position in 300357.SZ as of their last filing.
No one on the platform has traded 300357.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 20.4% | 26.4% | 32.4% | — | — | — |
| Rev. Growth % | 14.8% | 10.8% | ||||
| Profit Margin % | 35.9% | 37.5% | 41.4% | |||
| Free Cash Flow Margin % | 28.6% | 22.7% | 25.3% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $1.2B | +11.9% | $0.87 | $0.86–$0.88 | — | 1 |
| 2027 | $1.4B | +16.2% | $1.02 | $1.01–$1.03 | — | 1 |
| 2028 | $1.7B | +17.4% | $1.19 | $1.17–$1.21 | — | 2 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 0 of the last 2 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-04-18 | $0.15 | $0.09 | -42.0% |
| 2024-10-23 | $0.29 | $0.23 | -19.0% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 300357.SZZhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | $18.92 | -0.68% | $9.9B | — |
| 000739.SZApeloa Pharmaceutical Co.,Ltd | $22.37 | -1.37% | $25.9B | — |
| 002019.SZYifan Pharmaceutical Co., Ltd. | $9.24 | -0.75% | $11.2B | — |
| 002399.SZShenzhen Hepalink Pharmaceutical Group Co., Ltd. | $9.38 | -2.39% | $11.7B | — |
| 002755.SZBeijing Aosaikang Pharmaceutical Co., Ltd. |
| $11.26 |
| -1.23% |
| $10.5B |
| — |
| 300009.SZAnhui Anke Biotechnology (Group) Co., Ltd. | $7.96 | -1.36% | $13.3B | — |
| 300957.SZYunnan Botanee Bio-Technology Group Co.LTD | $31.12 | -0.38% | $13.1B | — |
Source: Financial Modeling Prep · peers by sector/industry